Republished review: Next generation sequencing for clinical diagnostics and personalised medicine: implications for the next generation cardiologist

被引：0
|
作者：
Ware, James S. [1 ,2 ]
Roberts, Angharad M. [1 ]
Cook, Stuart A. [1 ,3 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England
[2] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England
[3] Royal Brompton & Harefield NHS Trust, Cardiovasc Biomed Res Unit, London, England
来源：
POSTGRADUATE MEDICAL JOURNAL | 2012年 / 88卷 / 1038期
基金：
英国惠康基金; 英国医学研究理事会;
关键词：
LONG-QT SYNDROME; NONINVASIVE PRENATAL-DIAGNOSIS; DILATED CARDIOMYOPATHY; FETAL DNA; CLOPIDOGREL; MUTATIONS; POLYMORPHISMS; GENOTYPE; EFFICACY; OUTCOMES;
D O I：
10.1136/pgmj.2011.300742rep
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The fast moving field of genomic medicine is already impacting on clinical care and cardiologists are fortunate to be in a position to benefit early from the transformative advances in genomics. However, the challenges associated with genomics in the clinic in general, and with next generation sequencing technologies in particular, are significant and cardiologists need to be prepared if they wish to surf the wave of genomic opportunity. This paper presents an overview of the implications of next generation sequencing for clinical diagnostics and personalised medicine in the cardiology clinic.
引用
收藏
页码：234 / 239
页数：6
相关论文
共 50 条
  • [21] Next generation sequencing technologies in cancer diagnostics and therapeutics: A mini review
    Li, W.
    Zhao, K.
    Kirberger, M.
    Liao, W.
    Yan, Y.
    CELLULAR AND MOLECULAR BIOLOGY, 2015, 61 (05) : 91 - 102
  • [22] What Next? The Next Transit from Biology to Diagnostics: Next Generation Sequencing for Immunogenetics
    Gabriel, Christian
    Stabentheiner, Stephanie
    Danzer, Martin
    Proell, Johannes
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2011, 38 (05) : 308 - 317
  • [23] Next generation sequencing for inherited cardiomyopathies: implications for clinical practices
    Daoud, H.
    Ghani, M.
    Potter, R.
    Vasli, N.
    Chisholm, C.
    Ordorica, S.
    Smith, A.
    Jarinova, O.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1412 - 1413
  • [24] Clinical implications of next generation sequencing for the classification of endometrial carcinoma
    Sanchez, L.
    Perez-Buira, S.
    Rojo, F.
    VIRCHOWS ARCHIV, 2024, 485 : S431 - S431
  • [25] Next generation sequencing in clinical practice
    Matthijs, G.
    FEBS JOURNAL, 2012, 279 : 576 - 576
  • [26] Bioinformatics for Clinical Next Generation Sequencing
    Oliver, Gavin R.
    Hart, Steven N.
    Klee, Eric W.
    CLINICAL CHEMISTRY, 2015, 61 (01) : 124 - 135
  • [27] Clinical next generation sequencing in cancer
    Pfeifer, John D.
    CANCER GENETICS, 2013, 206 (12) : 409 - 412
  • [28] Next generation sequencing and a new era of medicine
    Casey, Graham
    Conti, David
    Haile, Robert
    Duggan, David
    GUT, 2013, 62 (06) : 920 - 932
  • [29] Application of Next Generation Sequencing in Laboratory Medicine
    Zhong, Yiming
    Xu, Feng
    Wu, Jinhua
    Schubert, Jeffrey
    Li, Marilyn M.
    ANNALS OF LABORATORY MEDICINE, 2021, 41 (01) : 25 - 43
  • [30] Targeted Next-Generation Sequencing can Replace Sanger Sequencing in Clinical Diagnostics
    Sikkema-Raddatz, Birgit
    Johansson, Lennart F.
    de Boer, Eddy N.
    Almomani, Rowida
    Boven, Ludolf G.
    van den Berg, Maarten P.
    van Spaendonck-Zwarts, Karin Y.
    van Tintelen, J. Peter
    Sijmons, Rolf H.
    Jongbloed, Jan D. H.
    Sinke, Richard J.
    HUMAN MUTATION, 2013, 34 (07) : 1035 - 1042
12345